vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Regency Centers (REG). Click either name above to swap in a different company.

Regency Centers is the larger business by last-quarter revenue ($404.2M vs $284.0M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 50.1%, a 46.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 8.5%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 5.4%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Regency Centers Corporation is a real estate investment trust based in Jacksonville, Florida, and is one of the largest operators of shopping centers with grocery stores as anchor tenants. As of October 21, 2020, the company owned 415 properties comprising 56-million-square feet of space. Notable properties owned by the company include Serramonte Center and a 30% interest in Village District.

ACAD vs REG — Head-to-Head

Bigger by revenue
REG
REG
1.4× larger
REG
$404.2M
$284.0M
ACAD
Growing faster (revenue YoY)
ACAD
ACAD
+0.9% gap
ACAD
9.4%
8.5%
REG
Higher net margin
ACAD
ACAD
46.2% more per $
ACAD
96.3%
50.1%
REG
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
5.4%
REG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
REG
REG
Revenue
$284.0M
$404.2M
Net Profit
$273.6M
$202.5M
Gross Margin
90.8%
Operating Margin
6.1%
71.0%
Net Margin
96.3%
50.1%
Revenue YoY
9.4%
8.5%
Net Profit YoY
90.3%
134.1%
EPS (diluted)
$1.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
REG
REG
Q4 25
$284.0M
$404.2M
Q3 25
$278.6M
$387.6M
Q2 25
$264.6M
$380.8M
Q1 25
$244.3M
$380.9M
Q4 24
$259.6M
$372.5M
Q3 24
$250.4M
$360.3M
Q2 24
$242.0M
$357.3M
Q1 24
$205.8M
$363.9M
Net Profit
ACAD
ACAD
REG
REG
Q4 25
$273.6M
$202.5M
Q3 25
$71.8M
$109.4M
Q2 25
$26.7M
$106.0M
Q1 25
$19.0M
$109.6M
Q4 24
$143.7M
$86.5M
Q3 24
$32.8M
$101.5M
Q2 24
$33.4M
$102.7M
Q1 24
$16.6M
$109.8M
Gross Margin
ACAD
ACAD
REG
REG
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Q1 24
88.8%
Operating Margin
ACAD
ACAD
REG
REG
Q4 25
6.1%
71.0%
Q3 25
12.8%
72.7%
Q2 25
12.2%
73.8%
Q1 25
7.9%
71.8%
Q4 24
59.1%
71.1%
Q3 24
12.6%
72.5%
Q2 24
12.6%
72.3%
Q1 24
7.4%
72.3%
Net Margin
ACAD
ACAD
REG
REG
Q4 25
96.3%
50.1%
Q3 25
25.8%
28.2%
Q2 25
10.1%
27.8%
Q1 25
7.8%
28.8%
Q4 24
55.4%
23.2%
Q3 24
13.1%
28.2%
Q2 24
13.8%
28.7%
Q1 24
8.0%
30.2%
EPS (diluted)
ACAD
ACAD
REG
REG
Q4 25
$1.61
Q3 25
$0.42
Q2 25
$0.16
Q1 25
$0.11
Q4 24
$0.86
Q3 24
$0.20
Q2 24
$0.20
Q1 24
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
REG
REG
Cash + ST InvestmentsLiquidity on hand
$177.7M
Total DebtLower is stronger
$4.7B
Stockholders' EquityBook value
$1.2B
$6.9B
Total Assets
$1.6B
$13.0B
Debt / EquityLower = less leverage
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
REG
REG
Q4 25
$177.7M
Q3 25
$258.0M
Q2 25
$253.6M
Q1 25
$217.7M
Q4 24
$319.6M
Q3 24
$155.1M
Q2 24
$177.1M
Q1 24
$204.7M
Total Debt
ACAD
ACAD
REG
REG
Q4 25
$4.7B
Q3 25
$4.9B
Q2 25
$4.8B
Q1 25
$4.6B
Q4 24
$4.4B
Q3 24
$4.4B
Q2 24
$4.4B
Q1 24
$4.4B
Stockholders' Equity
ACAD
ACAD
REG
REG
Q4 25
$1.2B
$6.9B
Q3 25
$917.3M
$6.8B
Q2 25
$822.4M
$6.7B
Q1 25
$765.2M
$6.7B
Q4 24
$732.8M
$6.7B
Q3 24
$577.2M
$6.8B
Q2 24
$516.7M
$6.8B
Q1 24
$464.0M
$7.0B
Total Assets
ACAD
ACAD
REG
REG
Q4 25
$1.6B
$13.0B
Q3 25
$1.3B
$13.1B
Q2 25
$1.2B
$12.7B
Q1 25
$1.1B
$12.6B
Q4 24
$1.2B
$12.4B
Q3 24
$976.9M
$12.4B
Q2 24
$914.1M
$12.4B
Q1 24
$855.1M
$12.7B
Debt / Equity
ACAD
ACAD
REG
REG
Q4 25
0.69×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.69×
Q4 24
0.66×
Q3 24
0.65×
Q2 24
0.64×
Q1 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
REG
REG
Operating Cash FlowLast quarter
$-48.7M
$203.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.18×
1.01×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
REG
REG
Q4 25
$-48.7M
$203.9M
Q3 25
$74.3M
$218.7M
Q2 25
$64.0M
$244.0M
Q1 25
$20.3M
$161.0M
Q4 24
$40.4M
$191.4M
Q3 24
$63.2M
$227.6M
Q2 24
$25.0M
$203.5M
Q1 24
$29.1M
$167.8M
Free Cash Flow
ACAD
ACAD
REG
REG
Q4 25
Q3 25
$73.9M
Q2 25
Q1 25
Q4 24
Q3 24
$63.2M
Q2 24
Q1 24
FCF Margin
ACAD
ACAD
REG
REG
Q4 25
Q3 25
26.5%
Q2 25
Q1 25
Q4 24
Q3 24
25.2%
Q2 24
Q1 24
Capex Intensity
ACAD
ACAD
REG
REG
Q4 25
Q3 25
0.1%
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
ACAD
ACAD
REG
REG
Q4 25
-0.18×
1.01×
Q3 25
1.03×
2.00×
Q2 25
2.40×
2.30×
Q1 25
1.07×
1.47×
Q4 24
0.28×
2.21×
Q3 24
1.93×
2.24×
Q2 24
0.75×
1.98×
Q1 24
1.76×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

REG
REG

Shopping Centers$418.0M103%
Propertymanagementservices$4.1M1%
Assetmanagementservices$1.7M0%

Related Comparisons